<SEC-DOCUMENT>0001169245-22-000003-index.html : 20220114 <SEC-HEADER>0001169245-22-000003.hdr.sgml : 20220114 <ACCEPTANCE-DATETIME>20220114170423 ACCESSION NUMBER: 0001169245-22-000003 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20220114 DATE AS OF CHANGE: 20220114 EFFECTIVENESS DATE: 20220114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-262185 FILM NUMBER: 22532559 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>s-8coverpagephasebiox2022s.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: s-8coverpagephasebiox2022s.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>ex51phas-2022evergreenandi.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: ex51phas-2022evergreenandi.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>ex231c-3phassx8consent_upd.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: ex231c-3phassx8consent_upd.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.3 <SEQUENCE>4 <FILENAME>ex993phasebio-2022induceme.htm <DESCRIPTION>EX-99.3 <TEXT> Document 4 - file: ex993phasebio-2022induceme.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>image_0.jpg <TEXT> Document 5 - file: image_0.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>image_1.jpg <TEXT> Document 6 - file: image_1.jpg
</DOCUMENT> </SEC-DOCUMENT>